Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOMERICA INCBMRA · Entity 8171 | Chief Financial Officer | December 12, 2025 | December 31, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOMERICA INC
Report date December 12, 2025 · Filed December 31, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 59,375 |
Reported balance
After 2025-12-12 transaction · row 1
1 source rowRow 1 · 2025-12-12 · Grant · Acquired 40,000 · Balance 59,375 F1: Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest over 4 years at 25% on each anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest over 4 years at 25% on each anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2025 Filed Dec 31, 2025 22:10 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantCommon stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-029843 · ownership.xml · nonDerivative · entry 1 Lu Gary · CIK 0001968621 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,375 F1 · shares: Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest over 4 years at 25% on each anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:30 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantCommon stock | 155,000 | $0.31 | $48,050.00 |
DisclosureSEC source: 0001493152-24-050503 · ownership.xml · nonDerivative · entry 1 Lu Gary · CIK 0001968621 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,000 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over 4 years at 25% on each anniversary of December 13, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| December 13, 2023 Filed Dec 14, 2023 22:10 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon-qualified stock option · Derivative | 155,000 | Not disclosed Strike: $1.01 | Not disclosed |
DisclosureSEC source: 0001493152-23-044911 · ownership.xml · derivative · entry 2 Lu Gary · CIK 0001968621 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,000 Underlying: Common Stock · 155,000 shares Expires 2033-12-13 F1 · shares: Options granted to Mr. Lu as part of his Fiscal 2024 executive compensation package. F3 · price: Not Applicable F2 · derivative.exercise_date: 25% vesting on 12/013/2024, 25% on 12/13/2025, 25% on 12/13/2026, and 25% on 12/13/2027 Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 18:43 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon-qualified stock option · Derivative | 100,000 | Not disclosed Strike: $1.74 | Not disclosed |
DisclosureSEC source: 0001513162-23-000057 · primary_doc.xml · derivative · entry 1 Lu Gary · CIK 0001968621 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 0 shares Expires 2033-04-06 F2 · price: Not applicable F1 · derivative.exercise_date: 25% exercisable on 12/9/2023, and 25% annually there after. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.